IL17A and metabolic dysfunction-associated steatohepatitis: Th17/resting regulatory T cell (Th17/rTreg) ratios were analyzed in relation to <i>IL17A</i> rs2275913 genotype in patients with MASLD (n = 58), including 31 with histology-proven MASH, and 28 healthy controls.<h4>Results</h4>We identified the <i>IL17A</i> rs2275913 minor allele variant as a risk factor for fibrosis progression in patients with MASLD.